Posted by Charles Blunt on Dec 14th, 2024
Gain Therapeutics, Inc. (NASDAQ:GANX – Get Free Report) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 580,600 shares, a decline...
More of this article »